PrecisionLife Co-founder and CEO, Dr Steve Gardner is presenting at the MassBio 2024 Align Summit, the premier partnering event for biotech funders and innovative life science companies disrupting drug discovery and development with groundbreaking science and technology.
Steve will present PrecisionLife - Driving Precision Medicine in Complex Chronic Diseases, on Thursday, April 25, 4:10 – 4:30PM in the Parkview Room (East Tower) of the Royal Sonesta Boston, Cambridge, MA.
The day will also include partnering meetings, keynotes, panel discussions, and presentations from innovative biotech and emerging AI/ML and precision medicine companies.
Attendees will have the opportunity to set up 1:1 partnering meetings with PrecisionLife CEO, Steve Gardner and SVP Healthcare, Simon Beaulah throughout the day.
PrecisionLife is a pioneering precision medicine company expanding the field beyond oncology and rare disease with its focus on complex chronic diseases, including CNS, autoimmune, cardiovascular, respiratory, and metabolic diseases that account for over 80% of healthcare spending.
We are unique in our ability to link mechanism of disease to specific patient subtypes that are likely to benefit from a drug targeting their specific mechanism. With this insight, we de-risk every stage of biopharma innovation, from target selection through to product launch and develop patient stratification biomarkers to enable patients likely to respond to be selected for clinical studies, be more accurately diagnosed and matched to the most effective personalized treatment.
This year's event is sold out so if you're unable to attend and wish to meet with PrecisionLife outside of the meeting, you can contact us via the form below.
If you're already registered for Align and would like to meet us, please contact us via the event partnering app.